Lisa Coussens, Ph.D., and John Crabbe, Ph.D., are named American Association for the Advancement of Science Fellows.

OHSU’s Partnership Project helps to improve treatment of HIV, and prevent the spread of disease.

In a story about the revelation of the world’s first gene-edited babies in China, Peter Barr-Gillespie, Ph.D., says the basic scientific research conducted at OHSU is more important than ever.

A cover story in the Portland Business Journal provides an in-depth look at OHSU’s Hospital Transfer Center. “The vision is the right patient at the right place at the right time with the right team,” said Matthias Merkel, M.D., Ph.D.

Amanda Risser, M.D., M.P.H., comments on the challenges of caring for women who use amphetamine during pregnancy. “The best treatment option for such patients is time and support,” she says.

Research conducted by Shoukhrat Mitalipov, Ph.D. is mentioned in ongoing discussions about the ethics and utilization of gene editing techniques.

Susan Tolle, M.D., describes new research on the changing trends of Physician Order for Life-Sustaining Treatment, which enables seriously ill patients to make their end-of-life care wishes clear.

Joel Nigg, Ph.D., comments on a recent study that outlines birth month as a potential factor for ADHD diagnosis in children. Despite study limitations, Nigg says “it is helpful to look at sociologic drivers of diagnosis to help sort out real cases where a child has a problem that needs to be treated.”

Daniel Hartung, Pharm.D., M.P.H., discusses elevated costs of multiple sclerosis drug, based his previously published research.

A three-paper series about the use of causal inference techniques to better understand and improve childbirth outcomes for mothers and babies, compiled by Ellen Tilden, Ph.D., C.N.M., and Jonathan Snowden, Ph.D.